Jonas Göran Ekblom

Président chez MOBERG PHARMA AB

Profil

Jonas Göran Ekblom is the founder of Anaborex, Inc. Current positions include Chief Executive Officer at Vascurie AB, Chairman at Moberg Pharma AB starting 2025, Chairman at Oblique Therapeutics AB since 2023, Director at Emplipharm AB since 2023, and Associate Professor at the University of Uppsala.
Former roles include Chief Executive Officer at BOWS Pharmaceuticals AG, President & Chief Executive Officer at Promore Pharma AB from 2010 to 2023, Chairman at Axelar AB from 2015 to 2019, Chairman at Ziccum AB, Chairman at EffRx Pharmaceuticals SA from 2016 to 2023, Chairman at Larkberget AB in 2024, Director at KLIFO A from 2011 to 2017, Director at The Releef Initiative from 2004 to 2018, Director at Pergamum AB from 2015 to 2024, Director at Emplicure AB, Director at World 5 Ventures from 2020 to 2022, President & Director at Edge of The World Strategies Corp.
from 2007 to 2022, Director at Pergasus AB, Principal at Pharmacia AB, Chief Operating Officer at Nanostream, Inc., Principal at Biovitrum AB, Principal at Invitrogen AB, and Principal at Sequenom GmbH.
Education includes a doctorate from the University of Uppsala, an undergraduate degree from the University of Stockholm, and a doctorate from USC School of Pharmacy.

Postes actifs de Jonas Göran Ekblom

Sociétés	Poste	Début
MOBERG PHARMA AB	Président	22/05/2025
Oblique Therapeutics AB	Président	01/01/2023
University of Uppsala	Corporate Officer/Principal	-

Anciens postes connus de Jonas Göran Ekblom

Sociétés	Poste	Fin
COMBIGENE AB	Président	10/12/2024
Pergamum AB	Directeur Général	01/01/2024
Promore Pharma AB	Directeur Général	01/01/2023
EffRx Pharmaceuticals SA	Président	01/01/2023
Edge of The World Strategies Corp.	President	01/01/2022